Steven Kozmary, MD
Pain Medicine · Las Vegas, NVNPI 1659337459
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 133 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 36 manufacturers reported payments, led by Nevro Corp. at 28.0% of the total. Reporting peaked in 2019 at $1,204 and has fallen 84.3% since, to $188 in 2025.
Across 133 payments — averaging $24.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$906
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$335
- Forte Bio-pharma LLC$291
- Stimwave Technologies Incorporated$200
- Medtronic$170
- AbbVie$168
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,240100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 24 | $906 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 17 | $335 |
| Forte Bio-pharma LLC | 5 | $291 |
| Stimwave Technologies Incorporated | 2 | $200 |
| Medtronic(2 entities) | 5 | $170 |
| AbbVie(2 entities) | 8 | $168 |
| Sentynl Therapeutics, Inc. | 16 | $141 |
| Piramal Critical Care | 4 | $113 |
| Pfizer | 6 | $110 |
| Amgen | 3 | $74 |
| Impel Pharmaceuticals Inc. | 3 | $67 |
| Biohaven Pharmaceuticals, Inc. | 3 | $52 |
| Si-bone, Inc. | 3 | $50 |
| Biodelivery Sciences International, Inc. | 3 | $45 |
| Indivior Inc. | 3 | $45 |
| Scilex Pharmaceuticals Inc. | 3 | $43 |
| Arbor Pharmaceuticals, Inc. | 3 | $40 |
| Tersera Therapeutics LLC | 2 | $38 |
| Flowonix Medical Incorporated | 1 | $30 |
| Assertio Therapeutics, Inc. | 2 | $25 |
| Johnson & Johnson | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| IBSA Pharma Inc. | 1 | $23 |
| Zyla Life Sciences, Inc. | 2 | $23 |
| Eisai Inc. | 1 | $22 |
| MDD US Operations, LLC | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Vertex | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Biotronik NRO, Inc. | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $15 |
| Boston Scientific | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,240 in reported general payments places this provider in the 55th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $3,638 |
| Gabapentin | 79 | $1,214 |
| Pregabalin | 19 | $669 |
| Diclofenac Sodium | 16 | $423 |
| Oxycodone Hcl | 15 | $358 |
| Ibuprofen | 32 | $304 |
| Tizanidine Hcl | 35 | $303 |
| Methocarbamol | 11 | $217 |
| Cyclobenzaprine Hcl | 18 | $102 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Las Vegas
- Kunal ParikhLas Vegas$26K
- Nader HelmiLas Vegas$25K
- Sungkook ParkLas Vegas$20K
- Pouya MohajerLas Vegas$17K
- David AlvaradoLas Vegas$15K
- Okwuchukwu ObiLas Vegas$15K
- Christopher FisherLas Vegas$13K
- Andrew KimLas Vegas$11K
- Neville CampbellLas Vegas$11K
- Heerak KangLas Vegas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.